The tumor microenvironment as a determinant of cancer cell survival: A possible mechanism for de novo drug resistance

Kenneth H. Shain, Terry H. Landowski, William S. Dalton

Research output: Contribution to journalReview article

88 Scopus citations

Abstract

The influence of the microenvironment in the pathogenesis and progression of human cancer has traditionally been considered in the context of solid tumors. More recently, evidence has been accumulating to support the role of the bone marrow microenvironment in hematologic malignancies as well, particularly in multiple myeloma. This review focuses on myeloma as a model to demonstrate that the bone marrow microenvironment provides a sanctuary against programmed cell death and promotes tumor cell survival and progression. Additionally, the protective effects of the bone marrow milieu may confer a protection from cytotoxic drugs, allowing the emergence of drug-resistant tumors. These advances may assist in the design of novel therapeutic approaches to enhance the efficacy of standard chemotherapeutic drugs.

Original languageEnglish (US)
Pages (from-to)557-563
Number of pages7
JournalCurrent Opinion in Oncology
Volume12
Issue number6
DOIs
StatePublished - Dec 1 2000

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'The tumor microenvironment as a determinant of cancer cell survival: A possible mechanism for de novo drug resistance'. Together they form a unique fingerprint.

  • Cite this